U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901270) titled 'Metabolic Changes in Heart Failure Patients Treated With Vericiguat' on Oct. 21.
Brief Summary: Heart failure is a condition in which the heart cannot pump blood as effectively as it should. It can cause symptoms such as shortness of breath, tiredness, and fluid retention. Vericiguat is a medication used in certain patients with heart failure whose symptoms have recently worsened.
The aim of this study is to better understand how vericiguat treatment is associated with changes in metabolism, heart function, and blood vessel health in patients with heart failure.
This is a prospective, observational study conducted at a single hosp...